This is an image preview.
Start a Free Account
to view the full image.

Sign Up for a Free Account For information on discounts, see Plans & Pricing

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Vaccinations during concurrent outbreaks of hepatitis A, invasive meningococcal disease, United States, 2021 to 2022

Download

Persons vaccinated by month and antigen during concurrent outbreaks of hepatitis A, invasive meningococcal disease, and mpox, Florida, USA, 2021 to 2022. The figure shows the number of adult persons (older than 18 years of age) vaccinated with their first dose, by month the first dose was administered. For hepatitis A, the number includes persons vaccinated with any Food and Drug Administration (FDA)-approved vaccine against hepatitis A virus. For meningococcal disease, the number includes persons vaccinated with any FDA-approved serogroup ACWY vaccine (Menveo [GlaxoSmithKline], Menactra [Sanofi Pasteur, Inc], MenQuadfi [Sanofi Pasteur, Inc]). For mpox, the number includes persons vaccinated with JYNNEOS (Bavarian Nordic). FDA, Food and Drug Administration. (Source: Doyle TJ, Gumke M, Stanek D, et al. Concurrent outbreaks of hepatitis a, invasive meningococcal disease, and mpox, Florida, USA, 2021-2022. Emerg Infect Dis 2024;30[4]:633-43. Public domain.)